Health Canada approves Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted vaccine
The authorised vaccine contains 15-μg of mRNA encoding the spike protein of the wild-type of SARS-CoV-2 and 15-μg…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Oct 22
The authorised vaccine contains 15-μg of mRNA encoding the spike protein of the wild-type of SARS-CoV-2 and 15-μg…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
04 Oct 22
The $68m acquisition of the NASDAQ-listed LogicBio Therapeutics is expected to accelerate Alexion’s expansion into genomic therapies by…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Oct 22
Sumitovant, which holds about 52% of Myovant, has proposed to acquire the remaining shares of the company at…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Sep 22
Novo Nordisk will gain exclusive global rights to develop and commercialise the NLRP3 inhibitors for a variety of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
29 Sep 22
The firm claimed in court that it has found a network responsible for the sale of counterfeit bottles…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Sep 22
The phase 3 confirmatory Clarity AD clinical trial of lecanemab also met all key secondary endpoints, while delivering…
27 Sep 22
Tembexa is an oral antiviral approved by the US Food and Drug Administration (FDA) for the treatment of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Sep 22
As per the terms of the agreement, Seagen will be granted an exclusive worldwide license for LAVA-1223 by…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Sep 22
The US District Court found both Merck patents regarding sitagliptin to be valid and infringed
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Sep 22
The transaction, which has been unanimously approved by the boards of directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates